Skip to main content
FinSpry Logo
FinSpry
DGX logo
DGX
(NYSE)
Quest Diagnostics Incorporated
$198.02-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Quest Diagnostics Incorporated (DGX) Stock Price & Financial Analysis

Quest Diagnostics Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$196.06 - $199.14
52-Week High$213.50
52-Week Low$157.20
Open$196.66
Volume519.86K
Average Volume (3M)519.86K
Market Cap22.38B
Shares Outstanding113.00M
P/E Ratio (TTM)22.52
Forward P/E19.60
Price to Sales (P/S)2.02
Price to Book (P/B)3.12
EV/EBITDA14.25
Revenue (TTM)11.04B
Net Income (TTM)992.00M
Free Cash Flow (TTM)1.36B
EPS (TTM)$8.86
Profit Margin8.99%
Operating Margin14.15%
Return on Equity (ROE)13.84%
Debt to Equity0.96
50-Day MA$197.60
200-Day MA$184.27
52-Week Change16.78%
Annual Dividend$3.20
Dividend Yield1.62%
Payout Ratio36.13%
Last Dividend Ex-DateApr 6, 2026

Frequently Asked Questions About Quest Diagnostics Incorporated

What is the current stock price for DGX?

As of the latest trading session, DGX stock trades at $198.02. The 52-week range is $157.20–$213.50, with a day range of $196.06–$199.14.

What is the P/E ratio for DGX?

Quest Diagnostics Incorporated's trailing P/E ratio is 22.5, meaning investors pay $22.5 for every $1 of annual earnings. The forward P/E is 19.6, reflecting analyst expectations for future earnings. Quest Diagnostics Incorporated operates in the Healthcare sector.

Does DGX pay dividends?

Yes, Quest Diagnostics Incorporated pays a 1.62% annual dividend yield ($3.20 per share). The payout ratio is 36.1%. The last ex-dividend date was 2026-04-06.

What do analysts recommend for DGX?

Based on 13 analysts, the consensus for DGX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of DGX?

Quest Diagnostics Incorporated's market capitalization is $22.38B, classifying it as a large-cap company. Quest Diagnostics Incorporated operates in the Healthcare sector within the Diagnostics & Research industry.